Multinational Point Prevalence Study on the Management of Diabesity in Hospitals

Active, not recruiting

• Conditions: Diabetes Mellitus; Obesity

• Registration Number: NCT06680674
• Lead Sponsor: Medical University of Vienna

Brief Summary

Diabetes related to obesity ("diabesity") is becoming increasingly prevalent. Hospitalizations among people with diabetes are frequent and glycaemic control is often suboptimal during these stays.

However, the pharmacological treatment of diabesity has made significant progress in recent years.

The objective of this study is to assess the management of diabesity in the international hospital setting. Aims include:

1. to determine the prevalence of causes and duration of hospitalization

2. to investigate the treatments used

3. to determine individual metabolic control achived This is a cross-sectional multi-centre study in which researchers will conduct a one-day point prevalence assessment in internal medicine wards.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2024-11-06
• Study First Submitted QC: 2024-11-07
• Study First Posted: 2024-11-08
• Study Start: 2024-11-13
• Primary Completion: 2025-03-18
• Status Verified: 2025-05
• Last Update Submitted: 2025-05-05
• Last Update Posted: 2025-05-08
• Study Completion: 2025-05-31

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

• Hospitalized at the time of the survey for any cause
• Diabetes diagnosis (Known / documented in medical history or newly diagnosed using ADA diagnostic criteria)
• Age ≥ 18 years
• Written informed consent

Exclusion Criteria

• Patients in wards and units other than internal medicine wards (such as outpatient areas, emergency departments, skilled nursing and intensive care units, etc.)
• Paediatric patients (Age < 18 years)
• Patients without a diabetes diagnosis

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of point-of-care glucose values	3 days	Mean number of point-of-care glucose measurements during hospitalization

Secondary Outcome Measures

Name	Time	Method
Severe hypoglycaemia	From day of admission to the day of data collection, i.e., November 14, 2024	Severe hypoglycaemia during admission (glucose \<40mg/dL)

Trial Locations

Locations (8)

General University Hospital in Prague; 🇨🇿 Prague, Czechia

University Hospital RWTH Aachen; 🇩🇪 Aachen, Germany

Rabin Medical Center, Hasharon Hospital; 🇮🇱 Petah Tikva, Israel

Riga East Clinical University Hospital; 🇱🇻 Riga, Latvia

Medical University of Vienna; 🇦🇹 Vienna, Austria

Hippokration General Hospital, Aristotle University of Thessaloniki; 🇬🇷 Thessaloniki, Greece

Rostov State Medical University; 🇷🇺 Rostov-on-Don, Russian Federation

Kanuni Sultan Suleyman Training and Research Hospital; 🇹🇷 Istanbul, Turkey